| P for PSA recurrence-free survival after prostatectomy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Subset | Scenarioa | N | Preoperative PSA-level | pT-stage | cT-stage | Gleason prostatectomy | Gleason biopsy | pN-stage | R-status | MAPT-expression |
All cancers | ||||||||||
 | 1 | 6467 | < 0.0001 | < 0.0001 | – | < 0.0001 | – | < 0.0001 | < 0.0001 | < 0.0001 |
 | 2 | 9690 | < 0.0001 | < 0.0001 | – | < 0.0001 | – | – | < 0.0001 | < 0.0001 |
 | 3 | 9545 | < 0.0001 | – | < 0.0001 | < 0.0001 | – | – | – | < 0.0001 |
 | 4 | 8146 | < 0.0001 | – | < 0.0001 | – | < 0.0001 | – | – | < 0.0001 |
ERG-negative | ||||||||||
 | 1 | 2541 | 0.0215 | < 0.0001 | – | < 0.0001 | – | 0.0005 | 0.0601 | 0.0195 |
 | 2 | 3873 | 0.0013 | < 0.0001 | – | < 0.0001 | – | – | < 0.0001 | 0.0180 |
 | 3 | 3833 | < 0.0001 | – | < 0.0001 | < 0.0001 | – | – | – | 0.0013 |
 | 4 | 3779 | < 0.0001 | – | < 0.0001 | – | < 0.0001 | – | – | < 0.0001 |
ERG-positive | ||||||||||
 | 1 | 1900 | 0.0005 | < 0.0001 | – | < 0.0001 | – | 0.0145 | 0.0010 | 0.0122 |
 | 2 | 2995 | < 0.0001 | < 0.0001 | – | < 0.0001 | – | – | < 0.0001 | 0.0185 |
 | 3 | 2944 | < 0.0001 | – | < 0.0001 | < 0.0001 | – | – | – | 0.0115 |
 | 4 | 2900 | < 0.0001 | – | < 0.0001 | – | < 0.0001 | – | – | 0.0003 |